_edite.png)
About Denovia
Our Mission
At Denovia Dental, our mission is simple:
Empower doctors. Elevate care. Build lasting legacies.
We believe dentistry thrives when dentists lead — not corporations.
That’s why we’re committed to providing real ownership, true clinical autonomy, and the full support needed to grow sustainably, without compromise.
Our platform exists to protect the heart of private practice, while helping doctors scale their impact, their influence, and their future.
We’re here to prove that values and vision can grow side by side — and that the best days of doctor-led dentistry are still ahead.
Our Story
At Denovia Dental, our story is rooted in the belief that dentists deserve more — more ownership, more autonomy, and more opportunity to grow without sacrificing what makes private practice special.
That belief began with Dr. James Willis, whose journey from a young associate in Fishersville, Virginia to leading a 20-practice, doctor-led group is a testament to what’s possible when values, vision, and grit guide the way. Built without outside investors or private equity, his story is proof: there’s a better path forward for dentists — and it’s only just beginning.
_edite.png)
To Our Future Partners
.jpg)
Dr. James Willis, DDS
Founder, Denovia
Dear Colleague,
Dentistry is changing fast—but one principle endures: the best outcomes occur when doctors lead. I launched Denovia to prove that a clinician-owned platform can deliver world-class patient care while still securing a dentist's future.
Today, with 20 thriving practices across Virginia, we stand at an inflection point. Rather than accept early exit offers, we are doubling down on our vision of a nationwide network powered by elite clinicians and doctor-owners who put patient care first.
What makes Denovia different?
• A true partnership model. Our 60/40 equity structure keeps clinical decision-making where it belongs—with you—while giving the platform strategic resources to accelerate growth.
• Shared services that lighten your load. Centralized revenue cycle, staff management and HR, procurement, marketing, and AI analytics free doctors to focus on patients, not paperwork.
• Culture first. Every location retains its identity, staff, and community ties; we add support, not red tape.
The road ahead
We are raising $25 million–$30 million of growth capital to begin Phase I of our expansion:
-
Acquire 15–20 elite practices (each $1 million–$4 million in revenue) at sensible multiples, moving us to roughly 40 offices.
-
Invite our current doctors—and 80 new high performers—to join the equity pool, turning clinical excellence into long-term wealth.
-
Build specialty verticals in full-arch implants, orthodontics, and pediatric dentistry to boost same-store growth.
-
Strengthen data and AI infrastructure for smarter case acceptance, payer negotiations, and real-time operating dashboards.
-
Executing Phase I positions Denovia to reach $150 million–$200 million in enterprise value within 36 months and charts a clear course to $300 million and beyond.
Why partner now?
• Predictable upside. Our integration playbook has historically lifted margins 15–20 percent within the first year.
• Talent magnet. Clinician autonomy and ownership attract producers who prefer purpose over hierarchy.
• Transparent exit path. At $25–$30 million in EBITDA and a conservative 12× multiple, the math works—cash yield today, multiple expansion tomorrow.
If you believe 100 extraordinary doctors can out-innovate any bloated corporate chain, let’s talk. I would welcome the chance to explore how Denovia can amplify your clinical impact and compound your equity.
With respect and gratitude,
James Willis, DDS
Founder & Chief Executive Officer, Denovia Dental
This letter is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security of Denovia or its affiliates. Securities will be offered solely through confidential offering documents and only to persons verified as accredited investors within the meaning of Rule 501(a) under the U.S. Securities Act of 1933, as amended, in reliance on Rule 506(c) of Regulation D.
Forward-Looking Statements: Projections of enterprise value, EBITDA, and margin expansion are forward-looking and based on current expectations. Actual results may differ materially due to execution risk, market conditions, regulatory changes, and financing availability. Past performance is not indicative of future results. Prospective investors should consult independent legal, tax, and financial advisers before making any investment decision.
_edite.png)